cdmo.directory
← Compare landing

Medpharm vs UPM Pharmaceuticals

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/medpharm/upm-inc

CategoryMedpharmUPM Pharmaceuticals
Listed sitecdmocdmo
SummarySpecialized CDMO for topical, transdermal, and transepithelial drug products offering formulation development, analytical testing, process scale-up, and GMP manufacturing from early development through commercialization.Independent, family-owned CDMO specializing in oral solids, semi-solids, and controlled-substance manufacturing with 475,000 sq ft cGMP facility in Bristol, TN; over 80 products commercialized.
Services
  • Formulation Development
  • CMC Analytical Development
  • Stability Testing & Storage
  • Process Development
  • Technology Transfer
  • Topical & Semi-Solid Manufacturing
  • Ophthalmic Manufacturing
  • Inhalation & Nasal Dosage Manufacturing
  • Secondary Packaging & Labeling
  • Serialization & Track-and-Trace
  • Quality Control Testing
  • Formulation Development
  • CMC Analytical Development
  • Stability Testing & Storage
  • Quality Control Testing
  • Process Development
  • Technology Transfer
  • Oral Solid Dosage Manufacturing
  • Topical & Semi-Solid Manufacturing
  • Secondary Packaging & Labeling
  • Serialization & Track-and-Trace
  • Controlled Substance Manufacturing
  • HPAPI Manufacturing (High-Potency)
Modalities
  • Small Molecule
  • Small Molecule
Indications
  • Dermatology
  • Ophthalmology
  • Respiratory
Data not yet provided.
Locations
  • Headquarters, Guildford, England, United Kingdom
  • US Operations, Durham, North Carolina, United States
  • Headquarters & Manufacturing Facility, Bristol, Tennessee, United States
CertificationsData not yet provided.Data not yet provided.
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.